Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avicanna Inc AVCNF


Primary Symbol: T.AVCN

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including oral, sublingual, topical and transdermal delivery. It has developed a pipeline of patent-pending drug candidates that are indication specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain and various neurological disorders. Its first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America. MyMedi.ca is a medical cannabis care platform that serves medical cannabis patients’ needs and enhances the patient's journey.


TSX:AVCN - Post by User

Comment by TomasGon Jul 01, 2020 9:15am
123 Views
Post# 31211730

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Attention

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Attention Amen to that. Management in way over their heads.
Russell1 wrote:

You delivered? To whom? Not your shareholders that bought in privately at $2 years ago, not to shareholders who bought in privately at $8 and certainly not to me when I purchased on the market above $7. That was the company line as shareholders watched the stock plummet..."we are the best, it's everyone else's fault this is happening". This is precisely the attitude that concerns me as a shareholder. Where is the responsibility for mistakes that led to this share price collapse? There always seems to be an excuse. You continue to say that the company is doing amazing things and it is "the most undervalued cannabis stock", you are disconnected from the reality of your situation mate. So if Avicanna is a stellar company and the news releases have been great (as one of your promotion team pointed out, although they were confused why nobody seemed to care which means they are terrible at their job if that wasn't already evident) then where does that leave things? I would propose that it is the inexperience of the executive team and their lack of leadership in the public markets that created this disconnect. That would be the only explanation for the share price collapse as the executive team shouted their own praises to the hills. Unfortunately companies aren't built on Hopeful123 nor on executives who spend their time attacking Stockhouse posts asking pertinent questions about the health of the company instead of trying to focus on building shareholder value. I am glad you are excited that the stock price will hit $2.50 or $3 in your best case projection, please don't forget about all of us shareholders who purchased shares well above these "dream" numbers.  

-Russ



<< Previous
Bullboard Posts
Next >>